Guidelines/Outcomes Task Force: Abby Van Voorhees, MD, Chair Task Force, Mark A. Bechtel,
MD, Boni E. Elewski, MD, Steven R. Feldman, MD, Cindy Francyn Hoffman, MD, Robert S…

This prospective long-term cohort study investigated the incidence of malignancies in
severe psoriasis patients treated with cyclosporine. A total of 1252 patients were followed …

The incidence of primary cutaneous melanoma has been increasing dramatically for several
decades. Melanoma accounts for the majority of skin cancer–related deaths, but treatment …

Critical to the proper management of pyoderma gangrenosum are correct diagnosis,
identification and treatment of any underlying disorder, and the proper choice of topical and …

• Cyclosporine is known to be effective in the treatment of psoriasis. In this study, we have
used oral cyclosporine (6 mg/kg per day) given for 5 to 30 weeks to 24 patients for the …

Cyclosporine inhibits the activation of helper T cells that may be pathogenic in alopecia
areata Therefore we treated six patients with alopecia areata (five men, one woman) with oral …

Objective The safety and efficacy of a 1% cream formulation of pimecrolimus, a selective,
nonsteroid immunomodulator, was studied in infants with atopic dermatitis (AD). Methods …

The purpose of this study was to explore the influence of perceived IT beliefs, task-technology
fit, attitude, self-efficacy, and subjective norm on behavioral intention of adopting …

While past studies on user-interface design focused on a particular system or application
using the experimental approach, we propose a theoretical model to assess the impact of …

The main recommendations for the use of ciclosporin in the management of psoriasis are: (i)
intermittent short courses (average of 12 weeks duration) of ciclosporin are preferable; (ii) …